Dabrafenib
Dabrafenib is a selective inhibitor of mutated forms of BRAF kinase (IC50s: 0.7/5 nM for B-Raf (V600E)/C-Raf).
| Catalog Number | T1903 |
| Alternative Name(s) | GSK2118436A , GSK2118436 |
| Research Area | MAPK |
| Molecular Formula | C23H20F3N5O2S2 |
| CAS# | 1195765-45-7 |
| SMILES | CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Dabrafenib |
| Additional Information | https://www.targetmol.com/datasheet/T1903 |